‘Intriguing and Sobering’: Enthusiasm Over Psilocybin’s Effect on Depression Tempered by Questions About Durability
November 3, 2022
(STAT News) – The hype around psychedelic therapy has been put to the test, with the publication Wednesday of the largest-ever study of psilocybin to treat depression. The Phase 2 trial found that the drug was effective — it reduced or eliminated symptoms in the short term in more than one-third of patients who took the highest dose — but not as dazzlingly powerful as earlier smaller studies had suggested. (Read More)